Cargando…

Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse

BACKGROUND: Conventional analysis of single-plex chromogenic immunohistochemistry (IHC) focused on quantitative but spatial analysis. How immune checkpoints localization related to non-small cell lung cancer (NSCLC) prognosis remained unclear. METHODS: Here, we analyzed ten immune checkpoints on 1,8...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Haoyue, Diao, Li, Zhou, Xiaofeng, Chen, Jie-Neng, Zhou, Yue, Fang, Qiyu, He, Yayi, Dziadziuszko, Rafal, Zhou, Caicun, Hirsch, Fred R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264317/ https://www.ncbi.nlm.nih.gov/pubmed/34295654 http://dx.doi.org/10.21037/tlcr-21-96

Ejemplares similares

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes
por: He, Yayi, et al.
Publicado: (2017)

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer
por: He, Yayi, et al.
Publicado: (2016)

The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
por: Liu, Yu, et al.
Publicado: (2021)

Double staining immunohistochemistry
por: Chen, Xiao, et al.
Publicado: (2010)

Combinational immunotherapy based on immune checkpoints inhibitors in small cell lung cancer: is this the beginning to reverse the refractory situation?
por: Guo, Haoyue, et al.
Publicado: (2020)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)
por: Guo, Haoyue, et al.
Publicado: (2021)

sLAG-3 in non-small-cell lung cancer patients’ serum
por: He, Yayi, et al.
Publicado: (2018)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

Treatment of spine metastases in cancer: a review
por: Chen, Yu, et al.
Publicado: (2019)

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
por: Deng, Juan, et al.
Publicado: (2019)

Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
por: Libard, Sylwia, et al.
Publicado: (2018)

Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2020)

Risk factors for nicotine dependence in Chinese patients with lung cancer
por: Gu, Fen, et al.
Publicado: (2018)

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer
por: Chen, Peixin, et al.
Publicado: (2023)

Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment
por: Carbone, Antonino, et al.
Publicado: (2019)

An Image Analysis Solution For Quantification and Determination of Immunohistochemistry Staining Reproducibility
por: Chlipala, Elizabeth A., et al.
Publicado: (2020)

Immunohistochemistry (IHC) staining of in-vitro cancer cell-generated tumoroids
por: Amereh, Meitham, et al.
Publicado: (2023)

Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor
por: Fang, Qiyu, et al.
Publicado: (2022)

The Use of BEREP4 Immunohistochemistry Staining for Detection of Basal Cell Carcinoma
por: Sunjaya, Anthony Paulo, et al.
Publicado: (2017)

Conventional histological and cytological staining with simultaneous immunohistochemistry enabled by invisible chromogens
por: Morrison, Larry E., et al.
Publicado: (2021)

Comparative assessment between objective and subjective methods in slides stained by immunohistochemistry
por: de Andrade Quintanilha Ribeiro, Fernando, et al.
Publicado: (2015)

Immunohistochemistry Staining-Proven Cytomegalovirus Colitis in Living Donor Liver Transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2022)

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
por: He, Yayi, et al.
Publicado: (2016)

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules
por: He, Yayi, et al.
Publicado: (2017)

Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies
por: Chatrian, Andrea, et al.
Publicado: (2021)

Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy
por: Fang, Qiyu, et al.
Publicado: (2022)

Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas
por: Kampf, Caroline, et al.
Publicado: (2012)

Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2(nd)/3(rd) Line Therapy in Patients with Lung Adenocarcinoma
por: He, Yayi, et al.
Publicado: (2016)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer
por: Dai, Jiawei, et al.
Publicado: (2021)

The application of artificial intelligence in lung cancer: a narrative review
por: Zhang, Huixian, et al.
Publicado: (2021)

Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains
por: Economou, Mary, et al.
Publicado: (2014)

Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer
por: Ando, Koji, et al.
Publicado: (2015)

Getting two birds with one stone: Combining immunohistochemistry and Azan staining in animal morphology
por: Beckers, Patrick, et al.
Publicado: (2021)

Double staining of elastic fibre and immunohistochemistry is helpful to differentiate pleural invasion of lung cancer
por: Shen, Guihua, et al.
Publicado: (2022)

Multiplex chromogenic immunohistochemistry to stain and analyze paraffin tissue sections from the mouse or human
por: Maiques, Oscar, et al.
Publicado: (2022)

Quantitative multiplex immunohistochemistry with colorimetric staining (QUIVER) may still benefit from MILAN
por: Bolognesi, Maddalena M., et al.
Publicado: (2023)

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer
por: He, Yayi, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer
por: Zhang, Liping, et al.
Publicado: (2015)

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations
por: Wang, Haowei, et al.
Publicado: (2023)

The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy
por: Zhou, Fei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_brdp04f3i4pi873itklcvfe7dd